List of classes of drugs and foreign regulatory authorities for the purposes of reliance on decisions or documents (IbR List): Veterinary  drugs

Find the eligible classes of veterinary drugs and their corresponding foreign regulatory authorities (FRAs) in the incorporated by reference (IbR) list under the Ministerial Reliance Order (the Order).

On this page

• About the IbR List
• The IbR List
• Part 1: New drug submissions (NDS) for veterinary drugs
• Part 2: Abbreviated new drug submissions (ANDS) for veterinary drugs
• Part 3: Supplements to drug submissions for veterinary drugs

About the IbR List

The “Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs” (the Order) came into force on July 15, 2026. Under the Order, certain information in a drug submission can be deemed to meet certain requirements of the Food and Drug Regulations based on a decision or document produced by an FRA.

The “List of classes of drugs and foreign regulatory authorities for the purposes of reliance on decisions or documents” (IbR List) is incorporated by reference into the Order. It indicates the classes of drugs and their corresponding FRAs that are eligible for deeming.

The IbR List is published as 2 distinct lists, this list for veterinary drugs and another list for human drugs. 

If you’re looking for information on human drugs eligible under the Order, visit the List of classes of drugs and foreign regulatory authorities for the purposes of reliance on decisions or documents (IbR List): Human drugs.

The IbR List has parts, divisions and subdivisions based on the type of submission and the deeming scenario:

• Part 1: New drug submissions (NDS)
  • Division 1: General deeming
  • Division 2: 120-day filing
  • Division 3: Joint review
• Part 2: Abbreviated new drug submissions (ANDS)
  • General deeming
• Part 3: Supplements to drug submissions
  • Division 1, subdivision 1: General deeming, supplements to new drug submissions (SNDS)
  • Division 1, subdivision 2: General deeming, supplements to abbreviated new drug submissions (SANDS)
  • Division 2: 120-day filing (SNDS)
  • Division 3: Joint review (SNDS)

Individual listings include:

• the class of drugs that is eligible for deeming
• qualifiers to help define the class of drugs (in some cases)
  • For example, qualifiers can restrict the class of drugs to certain target populations, indications or dosage forms
• the FRA on which a manufacturer can rely for that class of drugs
• the effective date which indicates when the listing was last amended

The same drug classes may appear in multiple parts and divisions of the IbR List.

Health Canada maintains and updates this List as required. Before making a change to the IbR List, an assessment will be done to determine whether the update is necessary for a health or safety purpose, or is otherwise in the public interest. That assessment will also seek to determine whether it is unlikely to result in unacceptable risks or uncertainties to health, safety or, if applicable, the environment, based on the Order’s benefits and conditions.

Learn more:

• The Ministerial Reliance Order: About the Order
• Draft guidance on Ministerial Reliance Order concerning decisions or documents on certain drugs by foreign regulatory authorities

The IbR List

Interpretation

• APVMA means the Australian Pesticides and Veterinary Medicines Authority for Australia
• EMA means the European Medicines Agency and the European Commission for the European Union
• NZMPI means the New Zealand Ministry for Primary Industries for New Zealand
• U.K. VMD means the United Kingdom Veterinary Medicines Directorate for the United Kingdom
• U.S. FDA means the United States Food and Drug Administration for the United States

Part 1: New drug submissions (NDS) for veterinary drugs

Part 2: Abbreviated new drug submissions (ANDS) for veterinary drugs

General deeming

Drug class	Qualifiers	Foreign regulatory authorities	Effective date
All veterinary drugs	Except antiparasitic veterinary drugs	APVMA, EMA, NZMPI, U.K. VMD, U.S. FDA	July 15, 2026
Antiparasitic veterinary drugs	-	U.S. FDA	July 15, 2026

Part 3: Supplements to drug submissions for veterinary drugs

Includes:

• supplement to new drug submissions (SNDS)
• supplements to abbreviated new drug submissions (SANDS)